ProQR Therapeutics N.V.
PRQRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PRQR. That does not mean none is planned.
Get an email about PRQR's next catalysts
Track ProQR Therapeutics (PRQR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer (CEO) Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.
Websitesepofarsen
Leber Congenital Amaurosis 10
QR-1123
Autosomal Dominant Retinitis Pigmentosa
QR-421a
Retinitis Pigmentosa
QR-010
Cystic Fibrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
sepofarsen | Phase 3 | Leber Congenital Amaurosis 10 | - | - |
QR-1123 | Phase 2 | Autosomal Dominant Retinitis Pigmentosa | - | - |
QR-421a | Phase 2 | Retinitis Pigmentosa | - | - |
QR-010 | Phase 2 | Cystic Fibrosis | - | - |
Frequently asked questions
What is in ProQR Therapeutics N.V.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in ProQR Therapeutics N.V.'s (PRQR) pipeline across Phase 3, Phase 2. Its lead program is sepofarsen (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ProQR Therapeutics N.V.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ProQR Therapeutics N.V. (PRQR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PRQR biotech catalysts?→
Add PRQR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ProQR Therapeutics N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.